
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options
Zaoqu Liu, Hui Xu, Siyuan Weng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Zaoqu Liu, Hui Xu, Siyuan Weng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Showing 26-50 of 44 citing articles:
Development of a Platelet-Related Prognostic Model for Colorectal Cancer
Pengcheng Wang, Wei Zhao, Hai–Lei Cao
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Pengcheng Wang, Wei Zhao, Hai–Lei Cao
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma
Yuyuan Zhang, Zaoqu Liu, Jie Li, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 241-255
Open Access | Times Cited: 3
Yuyuan Zhang, Zaoqu Liu, Jie Li, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 241-255
Open Access | Times Cited: 3
Rare FGFR fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis
Kengo Hiranuma, Yuka Asami, Mayumi Kobayashi Kato, et al.
Cancer Medicine (2023) Vol. 12, Iss. 17, pp. 17835-17848
Open Access | Times Cited: 3
Kengo Hiranuma, Yuka Asami, Mayumi Kobayashi Kato, et al.
Cancer Medicine (2023) Vol. 12, Iss. 17, pp. 17835-17848
Open Access | Times Cited: 3
Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy
Chunguang Guo, Zaoqu Liu, Can Cao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 5
Chunguang Guo, Zaoqu Liu, Can Cao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 5
A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC
Yimin Li, Ruotong Tian, Jiaxin Liu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 5
Yimin Li, Ruotong Tian, Jiaxin Liu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 5
Predicting Differences in Treatment Response and Survival Time of Lung Adenocarcinoma Patients Based on a Prognostic Risk Model of Glycolysis-Related Genes
Rongchang Zhao, Dan Ding, Yan Ding, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 5
Rongchang Zhao, Dan Ding, Yan Ding, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 5
Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma
Lei Dai, Joseph Mugaanyi, Xingchen Cai, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Lei Dai, Joseph Mugaanyi, Xingchen Cai, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 5
CD95 promotes stemness of colorectal cancer cells by lncRNA MALAT1
Chenyi Gao, Kun‐Peng Jia, Jun Fang, et al.
Life Sciences (2023) Vol. 338, pp. 122394-122394
Closed Access | Times Cited: 2
Chenyi Gao, Kun‐Peng Jia, Jun Fang, et al.
Life Sciences (2023) Vol. 338, pp. 122394-122394
Closed Access | Times Cited: 2
Experimental prognostic model integrating N6-methyladenosine-related programmed cell death genes in colorectal cancer
Qihui Wu, Xiaodan Fu, Xiaoyun He, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108720-108720
Open Access | Times Cited: 2
Qihui Wu, Xiaodan Fu, Xiaoyun He, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108720-108720
Open Access | Times Cited: 2
Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma
Guoliang Cui, Jinhui Liu, Manli Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Guoliang Cui, Jinhui Liu, Manli Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
A novel metabolite-interacting protein (MIP)-based molecular subtyping construction and validation of IGFBP3 as a MIP-related oncogene in colorectal cancer
Simeng Bao, Yongmin Li, Yu Liang, et al.
Genes & Diseases (2024) Vol. 12, Iss. 2, pp. 101272-101272
Open Access
Simeng Bao, Yongmin Li, Yu Liang, et al.
Genes & Diseases (2024) Vol. 12, Iss. 2, pp. 101272-101272
Open Access
Predicting Immunotherapy Efficacy with Machine Learning in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis
Sara Szincsak, Petèr Király, Gábor Szegvári, et al.
(2024)
Closed Access
Sara Szincsak, Petèr Király, Gábor Szegvári, et al.
(2024)
Closed Access
Involvement of ICAM5 in Carcinostasis Effects on LUAD Based on the ROS1-Related Prognostic Model
Baoliang Liu, Haotian Zheng, Guoyuan Ma, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6583-6602
Open Access
Baoliang Liu, Haotian Zheng, Guoyuan Ma, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6583-6602
Open Access
Aberrant glycosylation reveals unexpected clinical outcomes between Luminal B and Basal high stemness index breast cancer cohorts
M. Truter, Kevin J. Naidoo
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
M. Truter, Kevin J. Naidoo
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The T cell-mediated tumor killing patterns revealed tumor heterogeneous and proposed treatment recommendation in ovary cancer
Xinglin Wen, Beining Yin, Li Lin, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Xinglin Wen, Beining Yin, Li Lin, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
The Prognostic Model and Drug Sensitivity of LKB1-Mutant Lung Adenocarcinoma Based on Immune Landscape
Guanghui Wang, Haotian Zheng, Xiaogang Zhao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 2
Guanghui Wang, Haotian Zheng, Xiaogang Zhao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 2
The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas
Yueyang Ba, Jiahao Su, Shuang‐Qi Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 2
Yueyang Ba, Jiahao Su, Shuang‐Qi Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 2
Pan-cancer analysis reveals potential for synergy between SERPINA1 molecular targeting and macrophage-related immunotherapy
Chen Fu, Yuxi Miao, Xue Jiao, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Chen Fu, Yuxi Miao, Xue Jiao, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Integrative analysis of tumor stemness and immune microenvironment deciphers novel molecular subtypes in hepatocellular carcinoma
Zhiyi Wang, Shuang Chen, Dongxiao Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 101077-101077
Open Access
Zhiyi Wang, Shuang Chen, Dongxiao Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 5, pp. 101077-101077
Open Access